Drugmaker announces 7% increase as it seeks to garner support for Pascal Soriot’s £1.8m pay boost
Shareholders at AstraZeneca are in line for a 7% increase in dividends this year as the pharmaceutical company attempts to garner support for a pay deal worth up to £19m for its boss, Pascal Soriot.
AstraZeneca said it intended to increase the annual dividend for 2024 by $0.20 to $3.10 a share, reflecting its confidence in its performance and cash generation.
